Literature DB >> 10660128

Expression of desmoglein I and plakoglobin in skin carcinomas.

H Tada1, M Hatoko, A Tanaka, M Kuwahara, T Muramatsu.   

Abstract

Reduction or absence of cell-cell adhesion molecules has been reported in various carinomas and the abnormal expression of these molecules contributes to the invasive and metastatic behavior of malignant tumor cells. In epidermal keratinocytes, the main cell-cell adhesion systems are adherens junctions and desmosomes. Previous studies have shown that, in skin carcinomas, the decreased expression of E-cadherin, major constitutional glycoprotein of adherens junctions, is associated with the invasive and metastatic ability of the tumor cells. In the present study, we examined the expression of desmoglein I and plakoglobin, the constitutional components of desmosomes, in various skin carcinomas such as basal cell carcinoma (BCC), squamous cell carcinoma (SCC), extramammary Paget's disease and Bowen's disease by an immunofluorescence method. In normal human skin, desmoglein I and plakoglobin were strongly expressed in the intercellular space of the epidermis except for the basal cell layer. In BCC and SCC, the expression of desmoglein I and plakoglobin was markedly reduced or absent in tumor cells. In carcinoma in situ of Paget's disease, compared with the normal epidermal cells surrounding tumor cell nests, the expression of these molecules was reduced in tumor cells. In Paget's disease with dermal infiltration of tumor cells, the expression of these molecules was almost absent throughout the epidermis. In Bowen's disease, the expression of desmoglein I was reduced in the dumping cells and dyskeratotic cells. These results suggest that the expression of desmosomal cadherin is reduced or absent in human skin carcinomas, and that reduction of these molecules may also contribute to the invasiveness and metastasis of skin carcinomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10660128     DOI: 10.1034/j.1600-0560.2000.027001024.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  16 in total

1.  Reduced expression of plakoglobin correlates with adverse outcome in patients with neuroblastoma.

Authors:  R Amitay; D Nass; D Meitar; I Goldberg; B Davidson; L Trakhtenbrot; F Brok-Simoni; A Ben-Ze'ev; G Rechavi; Y Kaufmann
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 2.  Desmosomes: regulators of cellular signaling and adhesion in epidermal health and disease.

Authors:  Jodi L Johnson; Nicole A Najor; Kathleen J Green
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

Review 3.  Loss of E-Cadherin-Dependent Cell-Cell Adhesion and the Development and Progression of Cancer.

Authors:  Heather C Bruner; Patrick W B Derksen
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-03-01       Impact factor: 10.005

4.  Desmosome dynamics in migrating epithelial cells requires the actin cytoskeleton.

Authors:  Brett J Roberts; Anjeza Pashaj; Keith R Johnson; James K Wahl
Journal:  Exp Cell Res       Date:  2011-09-16       Impact factor: 3.905

5.  Desmoglein 1 Regulates Invadopodia by Suppressing EGFR/Erk Signaling in an Erbin-Dependent Manner.

Authors:  Hope E Burks; Christopher R Arnette; Alejandra Valenzuela-Iglesias; Amulya Yalamanchili; Oxana Nekrasova; Lisa M Godsel; Kathleen J Green
Journal:  Mol Cancer Res       Date:  2019-01-17       Impact factor: 5.852

6.  Analysis of beta-catenin mutations and alpha-, beta-, and gamma-catenin expression in normal and neoplastic human pituitary tissues.

Authors:  V Tziortzioti; K H Ruebel; T Kuroki; L Jin; B W Scheithauer; R V Lloyd
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 7.  Desmosomes: new perpetrators in tumour suppression.

Authors:  Rachel L Dusek; Laura D Attardi
Journal:  Nat Rev Cancer       Date:  2011-05       Impact factor: 60.716

Review 8.  Role of subtilisin-like convertases in cadherin processing or the conundrum to stall cadherin function by convertase inhibitors in cancer therapy.

Authors:  E J Müller; R Caldelari; H Posthaus
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

9.  Desmoglein-1, differentiation, and disease.

Authors:  Christoph M Hammers; John R Stanley
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

10.  Opposing prognostic relevance of junction plakoglobin in distinct prostate cancer patient subsets.

Authors:  Tanja Spethmann; Lukas Clemens Böckelmann; Vera Labitzky; Ann-Kristin Ahlers; Jennifer Schröder-Schwarz; Sarah Bonk; Ronald Simon; Guido Sauter; Hartwig Huland; Robert Kypta; Udo Schumacher; Tobias Lange
Journal:  Mol Oncol       Date:  2021-02-17       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.